FMP

FMP

Enter

INMD - InMode Ltd.

Financial Summary of InMode Ltd.(INMD), InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical produc

photo-url-https://financialmodelingprep.com/image-stock/INMD.png

InMode Ltd.

INMD

NASDAQ

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

17.37 USD

0.23 (1.32%)

About

ceo

Mr. Moshe Mizrahy

sector

Healthcare

industry

Medical - Devices

website

https://www.inmodemd.com

exchange

NASDAQ

Description

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reducti...

CIK

0001742692

ISIN

IL0011595993

CUSIP

M5425M103

Address

Tavor Building

Phone

972 4 909 6313

Country

IL

Employee

581

IPO Date

Aug 8, 2019

Summary

CIK

0001742692

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

M5425M103

ISIN

IL0011595993

Country

IL

Price

17.37

Beta

2.16

Volume Avg.

1.58M

Market Cap

1.47B

Shares

-

52-Week

16.96-48.25

DCF

32.69

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

7.55

P/B

-

Website

https://www.inmodemd.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest INMD News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep